18F-Fluciclovine Uptake in Intramuscular Injecting Site of Antiandrogen.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 35085174.
- Also identified by DOI 10.1097/RLU.0000000000004080.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
18F-fluciclovine, a radiolabeled amino acid analog, has been approved by US Food and Drug Administration for detecting lesions of biochemical recurrence of prostate adenocarcinoma with PET/CT. However, it is not specific for prostate cancer and has been found to be present in variety of malignant and benign etiologies. We herein present an interesting case of the incidental finding of increasing uptake of 18F-fluciclovine related to intramuscular injection of antiandrogen.
Medical subject headings
- Cyclobutanes
- Prostatic Neoplasms